BCL6 and neoplasm: There are reports demonstrating the druggability of BCL6 and the strong antiproliferative effect of its degradation [34], as well as evidence that the conditional deletion of BCL6 in DLBCL tumors in vivo induced significant inhibition of tumor growth with initial tumor stasis and subsequent attenuated tumor growth kinetics [35].